Christian Behrenbruch bought $997k of TLX
MD & Group CEO at Telix Pharmaceuticals Ltd. 67,935 shares at an average of $14.67, traded Apr 28, 2026, filed May 6, 2026.
Score components
- +25RoleCEO
- +25Trade size$997k at market
- -5Relative to holdingsUnder 1% of holdings (0.3%)
- +8Price context44% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -16.3%, 3m -6.2%, 6m -.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001628280-26-031608, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 28, 2026 | POpen-market purchase Ordinary Sharesindirect: Elk River Holdings Pty Ltd | +34,500 | $14.48 | $500k | 20,709,500 | May 6, 2026 |
| Apr 29, 2026 | POpen-market purchase Ordinary Sharesindirect: Elk River Holdings Pty Ltd | +33,435 | $14.87 | $497k | 20,742,935 | May 6, 2026 |
Related signals
Other insiders at Telix Pharmaceuticals Ltd and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | TLXbuy Telix Pharmaceuticals Ltd | Darren Charlton Smith Group Chief Financial Officer | $20k 2,071 shares | +17% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.